Home/Filings/4/0001209191-16-153395
4//SEC Filing

ACORDA THERAPEUTICS INC 4

Accession 0001209191-16-153395

CIK 0001008848operating

Filed

Dec 4, 7:00 PM ET

Accepted

Dec 5, 5:03 PM ET

Size

5.0 KB

Accession

0001209191-16-153395

Insider Transaction Report

Form 4
Period: 2016-12-01
Blight Andrew
Chief Scientifc Officer
Transactions
  • Sale

    Common Stock

    2016-12-01$20.76/sh4,855$100,77476,558 total
Footnotes (2)
  • [F1]Sales pursuant to a 10b5-1 plan.
  • [F2]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $20.30 to $21.15 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Issuer

ACORDA THERAPEUTICS INC

CIK 0001008848

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001008848

Filing Metadata

Form type
4
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 5:03 PM ET
Size
5.0 KB